Literature DB >> 23393473

Payers move slowly on test coverage decisions.

Bob Carlson.   

Abstract

Formulary decisions might be considered a snap when compared to decisions about coverage of a genetic test. The presence - or lack - of credible data to demonstrate cost-effectiveness is usually the touchstone.

Year:  2005        PMID： 23393473      PMCID： PMC3564335     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  2 in total

Review 1.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

2.  The strategic defense of physician autonomy: State public health agencies as countervailing powers.

Authors:  Laura Senier; Rachael Lee; Lauren Nicoll
Journal:  Soc Sci Med       Date:  2017-06-03       Impact factor: 4.634
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.